Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.89 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.39.
Market Cap
9.89T
Revenue
4.74T
Profits
213.26B
PE Ratio
46.39
Profit Margin
4.50%
Dividend Yield
0.38%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.21T | -0.79% | 3,806,347 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 664.95B | 1.43% | 8,861,277 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 514.92B | 1.07% | 5,041,277 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 361.73B | -0.14% | 7,628,508 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 353.17B | -0.40% | 5,904,923 | 450.06B |
| 6 | NVS | Novartis AG | 306.63B | 0.38% | 1,995,690 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 288.75B | -0.22% | 2,847,145 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 257.42B | 2.63% | 2,090,807 | 47.35B |
| 9 | AMGN | Amgen Inc. | 249.05B | 0.03% | 2,579,885 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.00B | -0.41% | 5,818,232 | 30.99B |
| 11 | ABT | Abbott Laboratories | 190.39B | -3.23% | 8,345,421 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 177.19B | 0.02% | 9,236,561 | 50.70B |
| 13 | PFE | Pfizer Inc. | 167.52B | -0.20% | 48,320,022 | 63.62B |
| 14 | DHR | Danaher Corporation | 161.99B | 1.73% | 4,061,120 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 156.96B | -3.36% | 2,151,324 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.71B | 0.85% | 1,271,668 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.02B | -1.57% | 9,796,112 | 50.03B |
| 18 | MDT | Medtronic plc | 124.62B | -2.90% | 7,451,384 | 37.54B |
| 19 | SYK | Stryker Corporation | 124.06B | -2.75% | 3,778,784 | 26.30B |
| 20 | MCK | McKesson Corporation | 122.48B | -1.04% | 812,151 | 418.79B |
| 21 | SNY | Sanofi | 111.86B | 0.28% | 3,896,334 | 57.89B |
| 22 | CVS | CVS Health Corporation | 107.28B | 3.10% | 16,104,802 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 103.40B | -2.46% | 1,462,444 | 78.70B |
| 24 | MRNA | Moderna, Inc. | 101.48B | 5.27% | 16,329,245 | 2.53B |
| 25 | GSK | GSK plc | 101.26B | -0.16% | 3,185,263 | 44.53B |
| 26 | ELV | Elevance Health, Inc. | 91.96B | -1.48% | 1,444,699 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 90.75B | 0.16% | 1,122,908 | 16.90B |
| 28 | CI | The Cigna Group | 77.36B | -2.62% | 2,429,952 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 66.18B | -0.80% | 2,968,892 | 29.86B |
| 30 | COR | Cencora, Inc. | 63.65B | -1.80% | 1,682,051 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 62.80B | 1.46% | 1,981,107 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 61.96B | -4.23% | 14,712,703 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 58.73B | 1.31% | 5,112,815 | 6.67B |
| 34 | BDX | Becton, Dickinson and Company | 57.71B | -0.78% | 2,172,633 | 19.46B |
| 35 | ARGX | argenx SE | 56.88B | 3.63% | 379,268 | 5.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 53.26B | 0.79% | 589,101 | 4.66B |
| 37 | MDLN | Medline Inc. | 52.14B | -0.30% | 8,998,248 | 30.68B |
| 38 | HUM | Humana Inc. | 52.08B | 5.33% | 2,576,473 | 154.19B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 49.72B | 1.99% | 6,196,558 | 17.23B |
| 40 | A | Agilent Technologies, Inc. | 49.27B | 1.73% | 2,048,563 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 49.18B | -2.05% | 1,746,508 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 46.49B | 5.09% | 941,743 | 6.61B |
| 43 | NTRA | Natera, Inc. | 45.05B | -14.59% | 5,777,245 | 2.91B |
| 44 | WAT | Waters Corporation | 44.96B | 1.00% | 695,786 | 5.61B |
| 45 | IQV | IQVIA Holdings Inc. | 44.80B | 2.62% | 1,398,400 | 17.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 41.59B | 8.24% | 4,497,777 | 197.56M |
| 47 | HLN | Haleon plc | 39.82B | -0.11% | 18,678,557 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.60B | -0.40% | 4,836,501 | 2.62B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.25B | -1.64% | 4,181,398 | 21.64B |
| 50 | BIIB | Biogen Inc. | 36.71B | 1.81% | 1,002,130 | 10.30B |
| 51 | ALC | Alcon Inc. | 36.15B | -2.10% | 3,172,347 | 10.86B |
| 52 | CNC | Centene Corporation | 34.53B | -5.97% | 5,814,143 | 180.41B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.51B | 2.57% | 350,589 | 4.20B |
| 54 | GMAB | Genmab A/S | 33.29B | 1.69% | 7,828,333 | 4.30B |
| 55 | RMD | ResMed Inc. | 33.10B | -1.68% | 1,717,922 | 5.73B |
| 56 | ZTS | Zoetis Inc. | 32.26B | -3.30% | 6,024,607 | 9.49B |
| 57 | ILMN | Illumina, Inc. | 32.23B | 2.47% | 2,064,518 | 4.54B |
| 58 | PHG | Koninklijke Philips N.V. | 29.79B | -0.52% | 1,789,473 | 20.16B |
| 59 | LH | Labcorp Holdings Inc. | 29.77B | 0.90% | 610,120 | 14.59B |
| 60 | DXCM | DexCom, Inc. | 29.62B | -5.98% | 3,937,533 | 5.10B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.12B | 0.35% | 945,181 | 11.84B |
| 62 | ROIV | Roivant Sciences Ltd. | 28.08B | 6.17% | 12,265,362 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 27.85B | 1.87% | 625,888 | 3.40B |
| 64 | INSM | Insmed Incorporated | 25.10B | 5.19% | 3,379,993 | 1.52B |
| 65 | STE | STERIS plc | 24.50B | -0.72% | 1,389,575 | 6.17B |
| 66 | INCY | Incyte Corporation | 24.39B | 1.39% | 1,486,495 | 6.01B |
| 67 | UTHR | United Therapeutics Corporation | 23.94B | -0.65% | 468,563 | 3.19B |
| 68 | VTRS | Viatris Inc. | 22.83B | 4.96% | 14,534,116 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.55B | -1.09% | 631,672 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.70B | 1.92% | 724,190 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.89B | -0.46% | 2,829,904 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.41B | -1.67% | 5,513,612 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.98B | -1.18% | 2,660,495 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.27B | 2.86% | 231,625 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.31B | 2.84% | 1,683,266 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 16.98B | 1.25% | 2,003,609 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.87B | 1.33% | 883,846 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.66B | 3.05% | 1,507,499 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.17B | 7.83% | 1,063,762 | 3.98B |
| 80 | SOLV | Solventum Corporation | 15.36B | 3.67% | 3,168,936 | 8.16B |
| 81 | ICLR | ICON Public Limited Company | 15.34B | 1.53% | 1,379,676 | 8.23B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 15.07B | 3.27% | 887,563 | 4.72B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.47B | 0.03% | 3,157,601 | 945.54M |
| 84 | BTSG | BrightSpring Health Services, Inc. | 13.99B | 1.96% | 2,482,892 | 15.25B |
| 85 | TEM | Tempus AI, Inc. | 13.87B | 7.98% | 6,284,519 | 1.51B |
| 86 | EHC | Encompass Health Corporation | 13.50B | -2.64% | 1,177,208 | 6.34B |
| 87 | BAX | Baxter International Inc. | 13.34B | 0.55% | 6,195,214 | 11.61B |
| 88 | GKOS | Glaukos Corporation | 13.28B | 2.01% | 1,202,866 | 690.33M |
| 89 | SMMT | Summit Therapeutics Inc. | 13.06B | 15.08% | 5,795,790 | - |
| 90 | SNN | Smith & Nephew plc | 12.99B | -2.69% | 1,863,760 | 6.30B |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.86B | 8.70% | 11,506,066 | 5.15B |
| 92 | PEN | Penumbra, Inc. | 12.58B | -0.59% | 336,729 | 1.56B |
| 93 | FMS | Fresenius Medical Care AG | 12.22B | -1.10% | 1,088,849 | 22.12B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.15B | 2.62% | 2,639,609 | 3.44B |
| 95 | DVA | DaVita Inc. | 12.04B | -1.78% | 603,734 | 14.17B |
| 96 | COO | The Cooper Companies, Inc. | 11.86B | -1.81% | 2,059,763 | 4.24B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.76B | -15.72% | 6,163,118 | 1.80B |
| 98 | ALGN | Align Technology, Inc. | 11.70B | 4.16% | 1,756,804 | 4.16B |
| 99 | UHS | Universal Health Services, Inc. | 11.52B | -1.56% | 740,169 | 18.35B |
| 100 | TECH | Bio-Techne Corporation | 11.41B | 0.17% | 2,307,628 | 1.23B |
| 101 | KYMR | Kymera Therapeutics, Inc. | 11.25B | 2.82% | 786,959 | 102.24M |
| 102 | RGEN | Repligen Corporation | 11.09B | 2.97% | 1,069,909 | 805.61M |
| 103 | MOH | Molina Healthcare, Inc. | 10.89B | -3.53% | 696,420 | 42.08B |
| 104 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | -0.16% | 2,733,264 | 3.66B |
| 105 | AVTR | Avantor, Inc. | 10.48B | 2.18% | 6,142,994 | 6.64B |
| 106 | ENSG | The Ensign Group, Inc. | 10.48B | -0.72% | 292,121 | 5.67B |
| 107 | QGEN | Qiagen N.V. | 10.39B | -1.04% | 3,394,157 | 2.12B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.26B | 3.41% | 273,160 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.16B | -6.16% | 1,568,174 | 3.19B |
| 110 | PCVX | Vaxcyte, Inc. | 10.11B | 3.18% | 1,841,189 | - |
| 111 | SYRE | Spyre Therapeutics, Inc. | 9.86B | 7.53% | 1,635,370 | - |
| 112 | HSIC | Henry Schein, Inc. | 9.51B | 0.87% | 1,375,033 | 13.73B |
| 113 | OSCR | Oscar Health, Inc. | 9.51B | -7.63% | 8,886,832 | 17.47B |
| 114 | GMED | Globus Medical, Inc. | 9.41B | -12.76% | 9,272,294 | 3.14B |
| 115 | HNGE | Hinge Health, Inc. | 9.34B | -0.19% | 1,540,717 | 800.82M |
| 116 | BRKR | Bruker Corporation | 9.34B | 5.60% | 2,012,718 | 3.51B |
| 117 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.28B | -0.12% | 1,088,724 | 1.43B |
| 118 | IBRX | ImmunityBio, Inc. | 9.15B | 7.80% | 9,274,185 | 165.79M |
| 119 | ATR | AptarGroup, Inc. | 9.03B | -1.07% | 505,064 | 3.99B |
| 120 | KRYS | Krystal Biotech, Inc. | 8.92B | 0.21% | 234,214 | 470.03M |
| 121 | HQY | HealthEquity, Inc. | 8.57B | 0.16% | 674,410 | 1.36B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.54B | -2.38% | 972,945 | 551.69M |
| 123 | TGTX | TG Therapeutics, Inc. | 8.49B | 3.18% | 2,305,800 | 799.54M |
| 124 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.22B | 1.22% | 1,363,197 | 669.50M |
| 125 | CORT | Corcept Therapeutics Incorporated | 7.96B | 1.59% | 1,406,677 | 963.65M |
| 126 | PACS | PACS Group, Inc. | 7.87B | -1.20% | 874,582 | 5.71B |
| 127 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.78B | 6.91% | 4,935,695 | 280.75M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 7.75B | 5.72% | 320,915 | 7.46M |
| 129 | TXG | 10x Genomics, Inc. | 7.72B | 2.10% | 4,523,288 | 618.58M |
| 130 | ALKS | Alkermes plc | 7.71B | 3.05% | 1,673,442 | 1.75B |
| 131 | TWST | Twist Bioscience Corporation | 7.57B | 0.15% | 2,055,315 | 431.80M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.50B | 1.84% | 827,192 | 5.33M |
| 133 | GRFS | Grifols, S.A. | 7.48B | -0.35% | 610,345 | 8.63B |
| 134 | CYTK | Cytokinetics, Incorporated | 7.46B | -3.35% | 2,562,876 | 113.29M |
| 135 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.37B | 6.25% | 636,346 | 945.96M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.24B | -3.07% | 10,289,412 | 1.05B |
| 137 | BLCO | Bausch + Lomb Corporation | 7.15B | 0.35% | 554,341 | 5.42B |
| 138 | AMRX | Amneal Pharmaceuticals, Inc. | 7.01B | 3.55% | 4,725,373 | 3.20B |
| 139 | AXSM | Axsome Therapeutics, Inc. | 6.96B | 1.98% | 718,397 | 865.27M |
| 140 | CHE | Chemed Corporation | 6.84B | -1.07% | 142,609 | 2.66B |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.81B | 7.12% | 1,071,383 | - |
| 142 | CGON | CG Oncology, Inc. | 6.74B | 17.27% | 3,661,960 | 6.17M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.09% | 1,575,980 | 1.56B |
| 144 | IONS | Ionis Pharmaceuticals, Inc. | 6.55B | 1.60% | 2,911,837 | 874.09M |
| 145 | IMVT | Immunovant, Inc. | 6.31B | 7.54% | 2,658,533 | - |
| 146 | KOD | Kodiak Sciences Inc. | 6.23B | 9.10% | 1,054,625 | - |
| 147 | BLTE | Belite Bio, Inc | 6.21B | 7.68% | 174,529 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.12B | 2.41% | 133,030 | 253.83M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.12B | 0.19% | 722,721 | 670.78M |
| 150 | HIMS | Hims & Hers Health, Inc. | 6.07B | 8.06% | 13,168,399 | 2.58B |
| 151 | TFX | Teleflex Incorporated | 5.98B | -0.84% | 948,147 | 2.26B |
| 152 | RDNT | RadNet, Inc. | 5.98B | -2.58% | 1,664,323 | 2.27B |
| 153 | DOCS | Doximity, Inc. | 5.80B | -2.02% | 4,293,169 | 661.58M |
| 154 | MANE | Veradermics, Incorporated | 5.80B | 7.92% | 503,271 | - |
| 155 | SRRK | Scholar Rock Holding Corporation | 5.72B | 3.16% | 2,096,407 | - |
| 156 | COGT | Cogent Biosciences, Inc. | 5.49B | 6.98% | 1,481,763 | - |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.47B | -0.35% | 898,968 | 1.16B |
| 158 | HAE | Haemonetics Corporation | 5.46B | -3.37% | 834,677 | 1.38B |
| 159 | WAY | Waystar Holding Corp. | 5.45B | -1.84% | 1,269,785 | 1.26B |
| 160 | GRAL | GRAIL, Inc. | 5.43B | 1.94% | 756,383 | 166.60M |
| 161 | SUPN | Supernus Pharmaceuticals, Inc. | 5.43B | -2.17% | 5,911,247 | 1.37B |
| 162 | CON | Concentra Group Holdings Parent, Inc. | 5.38B | 0.17% | 1,424,136 | 2.34B |
| 163 | BLLN | BillionToOne, Inc. | 5.38B | 1.38% | 993,251 | 436.87M |
| 164 | LFST | LifeStance Health Group, Inc. | 5.24B | 2.53% | 4,924,486 | 1.68B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.23B | -2.67% | 354,018 | 1.61B |
| 166 | ERAS | Erasca, Inc. | 5.04B | 8.59% | 4,032,150 | - |
| 167 | LIVN | LivaNova PLC | 4.96B | -1.26% | 443,996 | 1.51B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.93B | 15.87% | 3,716,881 | - |
| 169 | CRSP | CRISPR Therapeutics AG | 4.86B | 3.11% | 1,235,249 | 25.17M |
| 170 | DNTH | Dianthus Therapeutics, Inc. | 4.84B | 3.64% | 595,296 | 2.72M |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.76B | 1.49% | 1,012,203 | 651.03M |
| 172 | OPCH | Option Care Health, Inc. | 4.74B | 0.48% | 1,821,639 | 5.75B |
| 173 | MMED | MiniMed Group, Inc. | 4.70B | -7.98% | 7,479,451 | 3.22B |
| 174 | SHC | Sotera Health Company | 4.57B | 0.88% | 2,199,215 | 1.23B |
| 175 | HTFL | HeartFlow, Inc. | 4.56B | 0.87% | 969,877 | 212.07M |
| 176 | LEGN | Legend Biotech Corporation | 4.53B | 3.82% | 1,767,092 | 1.27B |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.53B | 4.29% | 3,333,526 | 298.01M |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.47B | 9.58% | 1,278,327 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.30B | 2.66% | 464,851 | 2.18B |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | -0.15% | 993,300 | 1.83B |
| 181 | CDNA | CareDx, Inc. | 4.13B | 2.92% | 1,126,412 | 497.40M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.11B | 9.41% | 3,200,741 | 10.35M |
| 183 | NVST | Envista Holdings Corporation | 4.04B | 0.84% | 3,234,824 | 2.88B |
| 184 | LQDA | Liquidia Corporation | 3.97B | -0.20% | 1,475,441 | 450.91M |
| 185 | ABCL | AbCellera Biologics Inc. | 3.85B | 6.74% | 2,210,673 | 66.17M |
| 186 | PLSE | Pulse Biosciences, Inc. | 3.80B | 0.41% | 428,499 | 1.49M |
| 187 | XENE | Xenon Pharmaceuticals Inc. | 3.79B | 3.95% | 869,646 | 7.50M |
| 188 | STVN | Stevanato Group S.p.A. | 3.71B | 2.73% | 1,365,050 | 1.42B |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.70B | 6.81% | 1,860,721 | -665.00K |
| 190 | ACAD | Acadia Pharmaceuticals Inc. | 3.67B | -0.05% | 1,770,851 | 1.20B |
| 191 | OGN | Organon & Co. | 3.64B | 0.58% | 3,947,238 | 6.10B |
| 192 | IOVA | Iovance Biotherapeutics, Inc. | 3.64B | 3.88% | 12,955,715 | 378.98M |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.63B | 3.02% | 2,129,303 | 53.81M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.62B | 10.36% | 969,794 | - |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.52B | 2.33% | 629,325 | 148.00K |
| 196 | IRON | Disc Medicine, Inc. | 3.50B | 0.56% | 717,551 | - |
| 197 | ACHC | Acadia Healthcare Company, Inc. | 3.44B | 6.35% | 4,534,091 | 3.41B |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.42B | 4.07% | 2,668,175 | - |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | 1.60% | 1,090,209 | 682.20M |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.37B | 4.09% | 2,359,189 | - |
| 201 | NHC | National HealthCare Corporation | 3.27B | 0.59% | 436,223 | 1.58B |
| 202 | CELC | Celcuity Inc. | 3.27B | 4.29% | 1,081,681 | - |
| 203 | VRDN | Viridian Therapeutics, Inc. | 3.24B | -0.21% | 4,501,358 | 26.31M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -5.37% | 3,262,351 | 508.68M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.22B | 1.77% | 1,586,648 | 21.38M |
| 206 | TLX | Telix Pharmaceuticals Limited | 3.19B | 2.23% | 311,773 | 890.79M |
| 207 | WRBY | Warby Parker Inc. | 3.17B | -2.30% | 5,095,122 | 934.66M |
| 208 | ZLAB | Zai Lab Limited | 3.16B | 12.74% | 1,894,887 | 441.73M |
| 209 | PRVA | Privia Health Group, Inc. | 3.12B | 2.01% | 2,807,726 | 2.43B |
| 210 | TMDX | TransMedics Group, Inc. | 3.06B | 27.92% | 3,952,848 | 727.65M |
| 211 | BHC | Bausch Health Companies Inc. | 3.06B | 2.76% | 3,067,556 | 11.11B |
| 212 | IRTC | iRhythm Holdings, Inc. | 3.03B | -30.70% | 5,667,138 | 854.04M |
| 213 | IDYA | IDEAYA Biosciences, Inc. | 3.02B | 1.92% | 1,652,527 | 36.54M |
| 214 | SGRY | Surgery Partners, Inc. | 3.01B | 0.13% | 3,114,295 | 3.37B |
| 215 | AXGN | Axogen, Inc. | 2.99B | 2.61% | 1,665,715 | 266.93M |
| 216 | ATRC | AtriCure, Inc. | 2.98B | -4.47% | 614,682 | 589.80M |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.89B | -3.07% | 1,805,099 | 2.60B |
| 218 | ADMA | ADMA Biologics, Inc. | 2.82B | -3.63% | 4,647,813 | 519.15M |
| 219 | VCEL | Vericel Corporation | 2.79B | 5.48% | 1,616,567 | 324.17M |
| 220 | XERS | Xeris Biopharma Holdings, Inc. | 2.78B | 16.21% | 7,897,218 | 368.26M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.69B | 6.32% | 1,085,466 | 1.46B |
| 222 | XNCR | Xencor, Inc. | 2.68B | 4.99% | 1,116,055 | 200.49M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.63B | 2.09% | 1,984,920 | 146.64M |
| 224 | RCUS | Arcus Biosciences, Inc. | 2.63B | 3.34% | 1,055,363 | 100.00M |
| 225 | RGC | Regencell Bioscience Holdings Limited | 2.61B | - | 207,844 | - |
| 226 | CLOV | Clover Health Investments, Corp. | 2.57B | 7.59% | 7,559,266 | 2.74B |
| 227 | NEOG | Neogen Corporation | 2.57B | 0.68% | 2,408,511 | 884.00M |
| 228 | PGNY | Progyny, Inc. | 2.57B | 1.37% | 1,550,907 | 1.34B |
| 229 | HCM | HUTCHMED (China) Limited | 2.56B | 6.76% | 157,312 | 549.12M |
| 230 | PVLA | Palvella Therapeutics, Inc. | 2.53B | 12.16% | 502,032 | - |
| 231 | MBX | MBX Biosciences, Inc. | 2.47B | 5.96% | 488,160 | - |
| 232 | ARDT | Ardent Health, Inc. | 2.44B | 8.81% | 3,465,796 | 6.45B |
| 233 | PHVS | Pharvaris N.V. | 2.41B | 5.72% | 405,107 | - |
| 234 | MD | Pediatrix Medical Group, Inc. | 2.38B | -1.73% | 491,258 | 1.96B |
| 235 | UFPT | UFP Technologies, Inc. | 2.35B | 1.22% | 103,710 | 649.52M |
| 236 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 5.66% | 926,320 | 158.00K |
| 237 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 7.57% | 427,951 | - |
| 238 | SEPN | Septerna, Inc. | 2.28B | 3.17% | 384,550 | 98.88M |
| 239 | ADUS | Addus HomeCare Corporation | 2.27B | -1.97% | 276,628 | 1.50B |
| 240 | NAMS | NewAmsterdam Pharma Company N.V. | 2.26B | 0.05% | 1,706,198 | 25.94M |
| 241 | SDGR | Schrödinger, Inc. | 2.24B | 3.65% | 1,429,116 | 269.20M |
| 242 | TRLV | Trulieve Cannabis Corp. | 2.23B | 6.06% | 1,551,606 | 1.08B |
| 243 | IMNM | Immunome, Inc. | 2.21B | 4.47% | 1,333,752 | 4.02M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.54% | 1,275,137 | 321.74M |
| 245 | PRGO | Perrigo Company plc | 2.20B | 0.89% | 2,314,635 | 4.09B |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | 0.57% | 15,585,949 | 68.23M |
| 247 | BHVN | Biohaven Ltd. | 2.19B | 4.17% | 2,921,603 | - |
| 248 | NEO | NeoGenomics, Inc. | 2.18B | 2.12% | 1,314,124 | 787.75M |
| 249 | VERA | Vera Therapeutics, Inc. | 2.15B | -1.18% | 2,078,214 | 10.28M |
| 250 | BKD | Brookdale Senior Living Inc. | 2.15B | -16.65% | 25,484,313 | 2.93B |
| 251 | FTRE | Fortrea Holdings Inc. | 2.12B | 7.33% | 1,941,806 | 2.67B |
| 252 | LKFT | Lakefront Biotherapeutics NV | 2.11B | -0.33% | 374,143 | 1.13B |
| 253 | ZYME | Zymeworks Inc. | 2.10B | 3.10% | 907,970 | 37.13M |
| 254 | VIR | Vir Biotechnology, Inc. | 2.09B | 10.80% | 1,896,933 | 302.80M |
| 255 | REPL | Replimune Group, Inc. | 2.05B | 7.99% | 2,975,062 | - |
| 256 | TRVI | Trevi Therapeutics, Inc. | 2.04B | 11.87% | 2,549,175 | - |
| 257 | PBH | Prestige Consumer Healthcare Inc. | 2.04B | -3.02% | 1,127,193 | 1.17B |
| 258 | TRAX | First Tracks Biotherapeutics, Inc. | 2.01B | 5.44% | 590,296 | - |
| 259 | ESTA | Establishment Labs Holdings Inc. | 2.00B | 4.04% | 321,680 | 264.03M |
| 260 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.98B | 0.79% | 5,210,860 | 961.51M |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.95B | 7.74% | 1,936,351 | 213.00M |
| 262 | VCYT | Veracyte, Inc. | 1.95B | 0.67% | 6,582,305 | 581.78M |
| 263 | ALMR | Alamar Biosciences, Inc. | 1.95B | 4.24% | 536,162 | 114.05M |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 1.97% | 787,173 | 989.36M |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | 1.42% | 2,596,795 | 1.96B |
| 266 | AGL | agilon health, inc. | 1.90B | -0.33% | 289,725 | 6.00B |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 1.87B | -6.24% | 10,284,544 | 3.58B |
| 268 | WGS | GeneDx Holdings Corp. | 1.86B | -3.09% | 1,204,589 | 454.43M |
| 269 | INSP | Inspire Medical Systems, Inc. | 1.85B | -3.83% | 490,607 | 880.94M |
| 270 | LMAT | LeMaitre Vascular, Inc. | 1.85B | -3.11% | 326,443 | 269.36M |
| 271 | MAZE | Maze Therapeutics, Inc. | 1.84B | 5.10% | 563,891 | 20.00M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 8.99% | 543,968 | 11.00M |
| 273 | CERT | Certara, Inc. | 1.84B | -1.07% | 4,871,056 | 425.76M |
| 274 | MESO | Mesoblast Limited | 1.81B | 1.21% | 192,844 | 120.25M |
| 275 | NVAX | Novavax, Inc. | 1.78B | 10.22% | 6,292,904 | 411.65M |
| 276 | LYCA | Lycia Therapeutics, Inc. | 1.76B | 5.90% | 370,060 | 4.44M |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.76B | 4.03% | 1,281,178 | 140.84M |
| 278 | ABSI | Absci Corporation | 1.75B | 8.31% | 4,161,242 | 1.56M |
| 279 | STOK | Stoke Therapeutics, Inc. | 1.74B | 1.80% | 1,162,631 | 28.21M |
| 280 | ALVO | Alvotech | 1.73B | 6.81% | 1,015,933 | 494.61M |
| 281 | OMCL | Omnicell, Inc. | 1.72B | -1.81% | 562,787 | 1.24B |
| 282 | AZTA | Azenta, Inc. | 1.72B | 4.76% | 792,084 | 613.81M |
| 283 | KMTS | Kestra Medical Technologies, Ltd. | 1.72B | 0.95% | 353,508 | 106.73M |
| 284 | PSNL | Personalis, Inc. | 1.71B | 1.54% | 3,000,201 | 80.77M |
| 285 | BFLY | Butterfly Network, Inc. | 1.70B | 4.94% | 3,476,196 | 123.26M |
| 286 | ASTH | Astrana Health, Inc. | 1.70B | -11.56% | 1,064,206 | 3.91B |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 1.70B | 6.85% | 7,623,254 | - |
| 288 | KLRA | Kailera Therapeutics, Inc. | 1.68B | 6.57% | 733,264 | - |
| 289 | GENB | Generate Biomedicines, Inc. | 1.68B | 3.90% | 632,195 | 26.48M |
| 290 | NRIX | Nurix Therapeutics, Inc. | 1.67B | 3.10% | 2,975,687 | 701.94M |
| 291 | HCSG | Healthcare Services Group, Inc. | 1.64B | -3.31% | 684,775 | 1.88B |
| 292 | ETON | Eton Pharmaceuticals, Inc. | 1.61B | 19.75% | 1,269,867 | 141.06M |
| 293 | PGEN | Precigen, Inc. | 1.60B | 5.92% | 9,238,231 | 156.94M |
| 294 | TDOC | Teladoc Health, Inc. | 1.60B | -6.80% | 5,729,637 | 2.47B |
| 295 | IMCR | Immunocore Holdings plc | 1.60B | 9.12% | 1,526,531 | 430.78M |
| 296 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 2.25% | 4,404,708 | 52.89M |
| 297 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | -0.90% | 4,049,187 | 730.00M |
| 298 | ENOV | Enovis Corporation | 1.57B | -5.10% | 2,304,737 | 2.31B |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.56B | -3.76% | 1,072,466 | 593.56M |
| 300 | NVCR | NovoCure Limited | 1.55B | -1.99% | 1,144,470 | 725.39M |
| 301 | ALHC | Alignment Healthcare, Inc. | 1.54B | -2.91% | 3,668,019 | 4.94B |
| 302 | CNMD | CONMED Corporation | 1.53B | -2.52% | 331,564 | 1.37B |
| 303 | NBTX | Nanobiotix S.A. | 1.53B | 2.03% | 136,240 | 13.15M |
| 304 | QURE | uniQure N.V. | 1.52B | 3.28% | 1,172,907 | 20.17M |
| 305 | BRVE | Braveheart Bio, Inc. | 1.52B | 6.77% | 702,051 | - |
| 306 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 2.36% | 295,069 | 829.86M |
| 307 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -0.45% | 440,017 | 6.13M |
| 308 | NUVB | Nuvation Bio Inc. | 1.47B | -0.72% | 5,335,950 | 201.73M |
| 309 | DMRA | Damora Therapeutics, Inc. | 1.47B | 8.42% | 360,453 | - |
| 310 | TYRA | Tyra Biosciences, Inc. | 1.45B | 1.24% | 862,266 | - |
| 311 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 537,093 | 743.30M |
| 312 | KARD | Kardigan, Inc. | 1.45B | 11.98% | 406,631 | - |
| 313 | GPCR | Structure Therapeutics Inc. | 1.45B | 6.66% | 1,621,152 | - |
| 314 | RAPP | Rapport Therapeutics, Inc. | 1.45B | 3.04% | 866,476 | 20.00M |
| 315 | OCUL | Ocular Therapeutix, Inc. | 1.45B | 2.57% | 1,957,239 | 52.06M |
| 316 | ANIP | ANI Pharmaceuticals, Inc. | 1.43B | -3.17% | 578,180 | 1.04B |
| 317 | KRSA | Korsana Biosciences, Inc. | 1.41B | 2.04% | 65,601 | - |
| 318 | TSHA | Taysha Gene Therapies, Inc. | 1.41B | 5.87% | 3,182,537 | 5.49M |
| 319 | AMN | AMN Healthcare Services, Inc. | 1.40B | -23.68% | 1,855,618 | 3.52B |
| 320 | ANAB | AnaptysBio, Inc. | 1.39B | 1.91% | 287,785 | 106.09M |
| 321 | AAPG | Ascentage Pharma Group International | 1.37B | 1.98% | 5,544 | 94.61M |
| 322 | INVA | Innoviva, Inc. | 1.36B | -0.73% | 1,654,268 | 438.32M |
| 323 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | 0.59% | 1,335,400 | - |
| 324 | LBRX | LB Pharmaceuticals Inc | 1.36B | 10.29% | 480,310 | - |
| 325 | PAHC | Phibro Animal Health Corporation | 1.34B | -6.89% | 283,677 | 1.54B |
| 326 | CRON | Cronos Group Inc. | 1.33B | -2.96% | 1,315,983 | 206.20M |
| 327 | AVLN | Avalyn Pharma Inc. | 1.29B | 9.30% | 630,263 | - |
| 328 | LMRI | Lumexa Imaging Holdings, Inc. | 1.29B | 1.67% | 322,865 | 1.04B |
| 329 | OPK | OPKO Health, Inc. | 1.28B | -1.14% | 6,903,966 | 654.10M |
| 330 | GHRS | GH Research PLC | 1.28B | 0.92% | 453,631 | - |
| 331 | PNTG | The Pennant Group, Inc. | 1.28B | -9.10% | 1,122,975 | 1.17B |
| 332 | NKTR | Nektar Therapeutics | 1.27B | 3.07% | 686,445 | 54.59M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.27B | 3.16% | 418,041 | - |
| 334 | STAA | STAAR Surgical Company | 1.27B | -5.65% | 1,041,649 | 328.27M |
| 335 | MNKD | MannKind Corporation | 1.25B | 3.72% | 4,985,292 | 413.37M |
| 336 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 5.28% | 220,248 | 1.30M |
| 337 | NUTX | Nutex Health Inc. | 1.24B | -6.75% | 168,324 | 796.53M |
| 338 | SGP | SpyGlass Pharma, Inc. | 1.24B | 8.41% | 109,376 | - |
| 339 | SVRA | Savara Inc. | 1.23B | 10.27% | 2,226,928 | - |
| 340 | OMER | Omeros Corporation | 1.22B | -0.88% | 1,016,466 | 38.42M |
| 341 | INNV | InnovAge Holding Corp. | 1.22B | -1.32% | 750,308 | 1.02B |
| 342 | VOR | Vor Biopharma Inc. | 1.22B | 6.54% | 555,463 | - |
| 343 | URGN | UroGen Pharma Ltd. | 1.21B | -3.81% | 1,761,232 | 250.25M |
| 344 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.21B | 3.00% | 826,255 | 745.79M |
| 345 | GDRX | GoodRx Holdings, Inc. | 1.20B | 0.57% | 1,174,072 | 785.23M |
| 346 | CMPS | COMPASS Pathways plc | 1.19B | 10.24% | 3,757,726 | - |
| 347 | SLN | Silence Therapeutics plc | 1.19B | 0.05% | 958,443 | 615.00K |
| 348 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 1.73% | 1,851,113 | 352.31M |
| 349 | TNDM | Tandem Diabetes Care, Inc. | 1.18B | -6.00% | 5,948,677 | 1.08B |
| 350 | AHG | Akso Health Group | 1.16B | 4.25% | 13,403 | 13.83M |
| 351 | ATEC | Alphatec Holdings, Inc. | 1.15B | -4.62% | 3,199,490 | 839.72M |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 5.44% | 227,030 | - |
| 353 | IRMD | IRADIMED CORPORATION | 1.10B | 0.90% | 222,103 | 89.34M |
| 354 | FRNM | Freenome, Inc. | 1.09B | -2.77% | 2,457,794 | 35.41M |
| 355 | SIBN | SI-BONE, Inc. | 1.09B | -0.12% | 683,474 | 220.65M |
| 356 | JANX | Janux Therapeutics, Inc. | 1.08B | 9.78% | 852,278 | 23.29M |
| 357 | VSTM | Verastem, Inc. | 1.06B | -10.34% | 7,038,351 | 100.30M |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.04B | -4.96% | 871,889 | 1.66B |
| 359 | CBLL | CeriBell, Inc. | 1.03B | 2.23% | 436,389 | 108.72M |
| 360 | HROW | Harrow, Inc. | 1.01B | 3.26% | 650,864 | 275.59M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.00B | -4.91% | 981,764 | 377.13M |
| 362 | ANRO | Alto Neuroscience, Inc. | 987.33M | 15.04% | 617,535 | - |
| 363 | AORT | Artivion, Inc. | 986.05M | -20.21% | 3,246,963 | 481.88M |
| 364 | MLTX | MoonLake Immunotherapeutics | 981.28M | 6.76% | 1,033,955 | - |
| 365 | AHCO | AdaptHealth Corp. | 979.22M | -1.08% | 2,287,014 | 3.44B |
| 366 | GMRS | GMR Solutions Inc. | 966.86M | -0.56% | 810,035 | 5.88B |
| 367 | JBIO | Jade Biosciences, Inc. | 958.41M | 6.88% | 596,541 | - |
| 368 | OMDA | Omada Health, Inc. | 935.52M | -20.37% | 4,716,105 | 333.04M |
| 369 | ODTX | Odyssey Therapeutics, Inc. | 921.91M | 1.85% | 577,256 | 99.00K |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 914.22M | 3.89% | 556,747 | - |
| 371 | CTY | City Therapeutics, Inc. | 908.06M | 6.91% | 311,821 | 14.34M |
| 372 | GLUE | Monte Rosa Therapeutics, Inc. | 901.76M | 3.12% | 1,005,563 | 70.33M |
| 373 | IVA | Inventiva S.A. | 895.70M | 4.68% | 2,220,601 | 2.81M |
| 374 | BVS | Bioventus Inc. | 894.01M | -0.66% | 642,470 | 585.64M |
| 375 | CRVS | Corvus Pharmaceuticals, Inc. | 886.63M | 8.32% | 1,257,480 | - |
| 376 | HSTM | HealthStream, Inc. | 883.92M | -2.40% | 249,954 | 327.95M |
| 377 | AKTS | Aktis Oncology, Inc. | 879.90M | 6.53% | 362,862 | 10.06M |
| 378 | IMTX | Immatics N.V. | 869.35M | 2.91% | 1,063,382 | 47.65M |
| 379 | PHAR | Pharming Group N.V. | 869.24M | -0.08% | 9,729 | 386.75M |
| 380 | MGTX | MeiraGTx Holdings plc | 864.39M | 5.76% | 703,329 | 397.50M |
| 381 | SNDX | Syndax Pharmaceuticals, Inc. | 858.87M | 1.81% | 4,171,071 | 289.68M |
| 382 | OBX | Obsidian Therapeutics, Inc. | 856.48M | 44.43% | 2,092,191 | - |
| 383 | BBNX | Beta Bionics, Inc. | 853.56M | 1.36% | 1,222,768 | 127.27M |
| 384 | LTGO | Latigo Biotherapeutics, Inc. | 835.37M | -3.15% | 556,053 | - |
| 385 | KIDS | OrthoPediatrics Corp. | 829.27M | -1.43% | 203,976 | 264.14M |
| 386 | PRME | Prime Medicine, Inc. | 827.26M | 4.49% | 3,059,122 | 4.07M |
| 387 | BBTX | Bambusa Therapeutics, Inc. | 801.32M | -0.76% | 218,962 | - |
| 388 | ANNX | Annexon, Inc. | 796.23M | 4.87% | 2,622,006 | - |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 792.02M | 10.56% | 3,601,340 | 38.54M |
| 390 | PHR | Phreesia, Inc. | 783.34M | -0.71% | 650,323 | 507.79M |
| 391 | ALMS | Alumis Inc. | 780.49M | 3.08% | 1,279,006 | 7.40M |
| 392 | VREX | Varex Imaging Corporation | 777.21M | - | 467,375 | 865.00M |
| 393 | INMD | InMode Ltd. | 766.22M | -0.52% | 657,829 | 374.63M |
| 394 | CTKB | Cytek Biosciences, Inc. | 762.47M | 7.96% | 1,132,270 | 207.65M |
| 395 | DNA | Ginkgo Bioworks Holdings, Inc. | 760.27M | 13.35% | 3,039,013 | 130.75M |
| 396 | COLL | Collegium Pharmaceutical, Inc. | 752.34M | -3.78% | 775,576 | 815.19M |
| 397 | RIGL | Rigel Pharmaceuticals, Inc. | 740.66M | -13.26% | 759,188 | 288.21M |
| 398 | SLDB | Solid Biosciences Inc. | 735.51M | 6.63% | 1,426,524 | - |
| 399 | QDEL | QuidelOrtho Corporation | 734.15M | -16.67% | 2,818,630 | 2.59B |
| 400 | OABI | OmniAb, Inc. | 733.68M | 4.14% | 1,442,552 | 40.21M |
| 401 | NVCT | Nuvectis Pharma, Inc. | 732.52M | 17.74% | 258,702 | - |
| 402 | CGEM | Cullinan Therapeutics, Inc. | 727.85M | 4.72% | 755,709 | - |
| 403 | IRWD | Ironwood Pharmaceuticals, Inc. | 725.40M | 8.93% | 3,963,432 | 400.30M |
| 404 | ARDX | Ardelyx, Inc. | 723.95M | -3.68% | 5,452,590 | 468.22M |
| 405 | ABUS | Arbutus Biopharma Corporation | 723.13M | -0.41% | 1,717,965 | 181.72M |
| 406 | SANA | Sana Biotechnology, Inc. | 709.48M | 1.28% | 2,305,390 | - |
| 407 | PACB | Pacific Biosciences of California, Inc. | 700.92M | -7.20% | 9,564,171 | 161.39M |
| 408 | SGMT | Sagimet Biosciences Inc. | 698.45M | 8.00% | 857,927 | - |
| 409 | ATTO | Attovia Therapeutics, Inc. | 697.09M | 1.80% | 218,754 | 1.80M |
| 410 | ACHV | Achieve Life Sciences, Inc. | 691.50M | 5.33% | 1,075,731 | - |
| 411 | ZVRA | Zevra Therapeutics, Inc. | 689.66M | 10.07% | 1,534,643 | 147.76M |
| 412 | AURA | Aura Biosciences, Inc. | 680.30M | 3.47% | 859,023 | - |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 676.74M | 8.89% | 993,257 | 92.01M |
| 414 | AVBP | ArriVent BioPharma, Inc. | 672.56M | 11.53% | 1,400,550 | - |
| 415 | CADL | Candel Therapeutics, Inc. | 669.54M | 8.83% | 955,020 | - |
| 416 | IMMX | Immix Biopharma, Inc. | 668.20M | 11.94% | 1,444,883 | - |
| 417 | WVE | Wave Life Sciences, Inc. | 663.68M | 4.50% | 2,205,149 | 70.92M |
| 418 | FLGT | Fulgent Genetics, Inc. | 663.27M | 27.22% | 1,097,522 | 330.28M |
| 419 | ANL | Adlai Nortye Group Ltd. | 662.01M | 6.20% | 531,007 | 18.06M |
| 420 | HELP | Helus Pharma Inc. | 654.62M | 6.79% | 1,210,025 | - |
| 421 | KURA | Kura Oncology, Inc. | 646.74M | 6.91% | 3,087,653 | 77.23M |
| 422 | OLMA | Olema Pharmaceuticals, Inc. | 641.36M | 8.43% | 1,337,270 | - |
| 423 | DSGN | Design Therapeutics, Inc. | 638.96M | 5.58% | 330,605 | - |
| 424 | GERN | Geron Corporation | 637.67M | 4.18% | 13,652,175 | 217.52M |
| 425 | DBVT | DBV Technologies S.A. | 628.83M | 6.63% | 210,654 | 3.74M |
| 426 | APMD | Apnimed, Inc. | 628.62M | 6.64% | 225,365 | 115.12M |
| 427 | EVO | Evotec SE | 627.05M | -4.79% | 66,977 | 815.72M |
| 428 | SOPH | SOPHiA GENETICS SA | 611.60M | 7.85% | 644,596 | 90.97M |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 604.44M | 8.03% | 3,526,327 | 6.40M |
| 430 | CLYM | Climb Bio, Inc. | 591.02M | 16.01% | 1,140,063 | - |
| 431 | TCMD | Tactile Systems Technology, Inc. | 583.11M | -1.29% | 192,189 | 356.42M |
| 432 | CBIO | Crescent Biopharma, Inc. | 579.53M | 4.64% | 137,774 | 11.88M |
| 433 | BCAX | Bicara Therapeutics Inc. | 572.40M | 5.62% | 1,010,560 | - |
| 434 | FTH | Faeth Therapeutics, Inc. | 569.78M | 10.69% | 539,427 | - |
| 435 | MYGN | Myriad Genetics, Inc. | 566.54M | -5.88% | 2,563,822 | 803.60M |
| 436 | SGHT | Sight Sciences, Inc. | 560.24M | 3.28% | 576,407 | 88.40M |
| 437 | OVID | Ovid Therapeutics Inc. | 556.60M | 10.47% | 3,897,580 | 1.58M |
| 438 | AVR | Anteris Technologies Global Corp. | 554.74M | 1.97% | 1,216,816 | 2.24M |
| 439 | NRC | NRC Health | 548.79M | 1.49% | 83,424 | 143.79M |
| 440 | ENTX | Entera Bio Ltd. | 546.12M | 5.02% | 118,328 | 42.00K |
| 441 | SRZN | Surrozen, Inc. | 542.35M | 6.90% | 140,729 | 11.51M |
| 442 | SLBT | SL Science Holding Limited | 534.62M | 4.16% | 53,778 | 3.27M |
| 443 | VALN | Valneva SE | 529.04M | -2.30% | 7,960 | 163.30M |
| 444 | CAPR | Capricor Therapeutics, Inc. | 523.25M | 4.65% | 4,664,303 | 11.13M |
| 445 | DCTH | Delcath Systems, Inc. | 518.05M | 3.04% | 696,857 | 95.42M |
| 446 | EVH | Evolent Health, Inc. | 518.02M | 0.88% | 1,743,941 | 2.34B |
| 447 | RCEL | AVITA Medical, Inc. | 513.08M | 5.80% | 1,137,593 | 84.68M |
| 448 | INDP | Indaptus Therapeutics, Inc. | 509.89M | 5.06% | 274,520 | - |
| 449 | GYRE | Gyre Therapeutics, Inc. | 509.65M | 18.70% | 359,716 | 110.06M |
| 450 | NGNE | Neurogene Inc. | 506.49M | -1.33% | 324,165 | 925.00K |
| 451 | DMAC | DiaMedica Therapeutics Inc. | 504.74M | 3.54% | 156,754 | - |
| 452 | MCTA | Charming Medical Limited | 504.26M | -0.02% | - | 4.81M |
| 453 | RGNX | REGENXBIO Inc. | 503.85M | 3.25% | 1,186,483 | 153.91M |
| 454 | SRTA | Strata Critical Medical, Inc. | 496.62M | 5.70% | 1,354,886 | 280.76M |
| 455 | ANGO | AngioDynamics, Inc. | 493.30M | -0.68% | 363,715 | 325.38M |
| 456 | ETRA | Electra Therapeutics, Inc. | 489.58M | 6.12% | 401,302 | - |
| 457 | MDXG | MiMedx Group, Inc. | 483.01M | 0.91% | 1,106,856 | 303.73M |
| 458 | IAM | Iambic Therapeutics, Inc. | 482.07M | -12.63% | 672,498 | 18.25M |
| 459 | TKNO | Alpha Teknova, Inc. | 481.90M | -0.89% | 546,535 | 45.95M |
| 460 | MNPR | Monopar Therapeutics Inc. | 479.38M | 6.25% | 94,209 | - |
| 461 | CTMX | CytomX Therapeutics, Inc. | 477.20M | 2.34% | 2,727,240 | 14.03M |
| 462 | STTK | Shattuck Labs, Inc. | 463.68M | 2.90% | 1,148,335 | 1.00M |
| 463 | OCS | Oculis Holding AG | 462.37M | 9.66% | 404,086 | 1.12M |
| 464 | SENS | Senseonics Holdings, Inc. | 454.19M | 7.51% | 867,663 | 48.55M |
| 465 | EPRX | Eupraxia Pharmaceuticals Inc. | 453.94M | 4.39% | 585,090 | - |
| 466 | AQST | Aquestive Therapeutics, Inc. | 453.73M | -1.37% | 4,143,548 | 48.84M |
| 467 | EOLS | Evolus, Inc. | 450.10M | 0.07% | 1,521,614 | 325.47M |
| 468 | BWAY | BrainsWay Ltd. | 441.02M | 5.09% | 103,039 | 60.70M |
| 469 | MASS | 908 Devices Inc. | 436.48M | 4.04% | 332,873 | 60.84M |
| 470 | BLSM | BlossomHill Therapeutics, Inc. | 429.10M | 9.31% | 174,332 | - |
| 471 | NPCE | NeuroPace, Inc. | 429.05M | -1.50% | 128,446 | 106.99M |
| 472 | TLRY | Tilray Brands, Inc. | 428.25M | 3.91% | 4,466,778 | 963.10M |
| 473 | SI | Shoulder Innovations, Inc. | 427.62M | 0.83% | 228,746 | 64.49M |
| 474 | PBYI | Puma Biotechnology, Inc. | 425.87M | -15.56% | 1,279,882 | 231.87M |
| 475 | YDES | YD Bio Limited | 422.86M | -16.85% | 207,609 | 1.24M |
| 476 | SSII | SS Innovations International, Inc. | 422.81M | 11.05% | 87,788 | 52.40M |
| 477 | ARVN | Arvinas, Inc. | 419.76M | -2.14% | 1,212,726 | 275.30M |
| 478 | PHAT | Phathom Pharmaceuticals, Inc. | 417.01M | 3.35% | 1,770,849 | 274.88M |
| 479 | RLMD | Relmada Therapeutics, Inc. | 416.01M | 3.45% | 1,055,411 | - |
| 480 | ASMB | Assembly Biosciences, Inc. | 415.76M | 2.10% | 249,358 | 74.85M |
| 481 | CRMD | CorMedix Inc. | 414.66M | 1.72% | 1,616,987 | 462.25M |
| 482 | PRTA | Prothena Corporation plc | 409.16M | 1.01% | 421,782 | 52.74M |
| 483 | CERS | Cerus Corporation | 407.95M | -5.16% | 2,070,872 | 226.57M |
| 484 | RZLT | Rezolute, Inc. | 407.00M | 6.59% | 1,520,531 | - |
| 485 | KMDA | Kamada Ltd. | 404.85M | 5.24% | 101,842 | 191.85M |
| 486 | ALT | Altimmune, Inc. | 404.60M | 5.58% | 2,773,868 | 31.00K |
| 487 | TECX | Tectonic Therapeutic, Inc. | 403.50M | 6.28% | 310,817 | - |
| 488 | CARL | Carlsmed, Inc. | 396.44M | -5.22% | 94,517 | 63.30M |
| 489 | EDIT | Editas Medicine, Inc. | 394.70M | 0.78% | 1,716,919 | 47.01M |
| 490 | ZURA | Zura Bio Limited | 393.97M | 9.95% | 3,006,104 | - |
| 491 | MPLT | MapLight Therapeutics, Inc. | 385.14M | 11.41% | 501,985 | - |
| 492 | CTEV | Claritev Corporation | 384.88M | 12.31% | 163,935 | 994.67M |
| 493 | CCCC | C4 Therapeutics, Inc. | 381.38M | 5.08% | 4,325,794 | 32.28M |
| 494 | AGMB | AgomAb Therapeutics NV | 376.01M | 9.54% | 158,411 | - |
| 495 | CTNM | Contineum Therapeutics, Inc. | 373.81M | 8.06% | 343,536 | - |
| 496 | AVTX | Avalo Therapeutics, Inc. | 373.69M | 4.52% | 1,112,295 | 59.00K |
| 497 | MOBI | Mobia Medical, Inc. | 372.53M | -0.80% | 223,809 | 51.89M |
| 498 | PRLD | Prelude Therapeutics Incorporated | 370.78M | 1.27% | 140,545 | 22.42M |
| 499 | STLN | Starling Oncology, Inc. | 369.21M | -45.97% | 23,917,528 | 620.45M |
| 500 | LYEL | Lyell Immunopharma, Inc. | 365.34M | -0.93% | 250,936 | 15.00K |